Germany’s BioNTech said it was on track to introduce a COVID-19 shot by the early fall in the northern hemisphere that is adapted to currently dominant virus variants in line with recommendations by the World Health Organization.
https://www.pharmalive.com/wp-content/uploads/2021/11/BioNTechs-skin-cancer-therapy-wins-FDAs-fast-track-designation-Reuters-11-19-21.jpg503960Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2023-05-25 08:47:512023-05-25 10:09:24BioNTech is proceeding with COVID-shot in line with WHO guidance
